Avandia and Heavy or prolong menstrual bleeding - a phase IV clinical study of FDA data

Summary:

Heavy or prolong menstrual bleeding is reported as a side effect among people who take Avandia (rosiglitazone maleate), especially for people who are 50-59 old, have been taking the drug for 2 - 5 years also take Avapro, and have Headache.

The phase IV clinical study analyzes which people have Heavy or prolong menstrual bleeding when taking Avandia. It is created by eHealthMe based on reports of 141,991 people who have side effects when taking Avandia from the FDA, and is updated regularly.

What is Avandia?

Avandia has active ingredients of rosiglitazone maleate. It is often used in diabetes. eHealthMe is studying from 142,155 Avandia users. Check the latest studies of Avandia.

What is Heavy or prolong menstrual bleeding?

Heavy or prolong menstrual bleeding is found to be associated with 748 drugs and 1,264 conditions by eHealthMe. Check the latest studies of Heavy or prolong menstrual bleeding.

On Jul, 20, 2026

141,991 people reported to have side effects when taking Avandia.
Among them, 30 people (0.02%) have Heavy or prolong menstrual bleeding.

Could Avandia cause Heavy or prolong menstrual bleeding?

Among these 30 people:

How long have people been on Avandia when they have Heavy or prolong menstrual bleeding? *

What is the age of people who have Heavy or prolong menstrual bleeding when taking Avandia? *

What are other drugs people take besides Avandia? *

What are other side effects people have besides Heavy or prolong menstrual bleeding? *

Abdominal Pain: 9 people, 30.00%
Joint Pain: 9 people, 30.00%
Headache (pain in head): 8 people, 26.67%
Weakness: 8 people, 26.67%
The Flu (the flu is caused by an influenza virus): 8 people, 26.67%
High Blood Pressure: 7 people, 23.33%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 23.33%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 23.33%
Fatigue (feeling of tiredness): 7 people, 23.33%
Abdominal Pain Upper: 7 people, 23.33%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 6 people, 20.00%
High Blood Pressure: 6 people, 20.00%
Headache (pain in head): 6 people, 20.00%
Sleep Disorder: 2 people, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 6.67%
Birth Control: 2 people, 6.67%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 3.33%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 3.33%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 3.33%
Depression: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Avandia and have Heavy or prolong menstrual bleeding?

- Check whether Heavy or prolong menstrual bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avandia:

Avandia (142,155 reports)

Browse all side effects of Avandia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (748 drugs)

Browse all the conditions that are associated with Heavy or prolong menstrual bleeding:

Heavy or prolong menstrual bleeding (1,264 conditions)

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on rosiglitazone maleate (the active ingredients of Avandia) and Avandia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.